Home Markets US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug Andrew M Jul 27, 2024 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/us-fda-warns-of-dosing-errors-with-compounded-versions-of-novos-weight-loss-drugs-3539477 Dosing FDA Market Updates www.investing.com/news/stock-market-news/us-fda-warns-of-dosing-errors-with-compounded-versions-of-novos-weight-loss-drugs-3539477